期刊文献+

EB病毒抑制小肠上皮细胞增殖的ERK1/2途径分析 被引量:1

Effect of EB virus on growth of intestinal epithelial cells via ERK1/2 pathway
原文传递
导出
摘要 目的分析EB病毒(EB virus,EBV)抑制小肠上皮细胞增殖的机理,初步探讨EBV导致腹泻的病理机制。方法应用EBV作用于小肠上皮细胞,作用后0、12、24、36和48 h,采用MTT法检测细胞的增殖情况,Western blot法检测细胞MAPK(磷酸化的ERK1/2、JNK、p38)通路的表达情况。结果经EBV作用36及48 h的小肠上皮细胞存活率较24及12 h显著降低,并显著低于0 h(P <0. 05);磷酸化ERK1/2的表达在36和48 h最低,显著低于其他3个时间点(P <0. 05)。结论 EBV可抑制小肠上皮细胞的增殖,且通过抑制ERK1/2磷酸化途径实现。本实验为进一步研究EBV导致腹泻的发病机理提供了参考。 Objective To analyze the mechanism of EB virus(EBV)in inhibiting the proliferation of intestinal epithelial cells and causing diarrhea.Methods Intestinal epithelial cells were inoculated with EBV for 0,12,24,36 and 48 h,and determined for proliferation by MTT assay.The expression of MAPK(phosphorylated ERK1/2,phosphorylated JNK and phosphorylated p38) pathway was determined by Western blot.Results The survival rates of intestinal epithelial cells 36 and 48 h were significantly lower than those 12 and 24 h after inoculation with EBV as well as that before inoculation(0 h,P<0.05).However,the expression levels of phosphorylated ERK1/2(p-ERK1/2) 36 and 48 h were significantly lower than those at the other three time points after inoculation(P<0.05).Conclusion EBV inhibited the proliferation of intestinal epithelial cells via ERK1/2 pathway.It laid a foundation of further study on the pathological mechanism of diarrhea caused by EBV.
作者 胡香珍 张艳飞 HU Xiang-zhen;ZHANG Yan-fei(Department of Gastroenterology,Affiliated Hospital of lnner Mongolia Medical University.Inner Mongolia,Hohhat 010050,Inner Mongolia Autonomous Region,China)
出处 《中国生物制品学杂志》 CAS CSCD 2019年第1期46-48,共3页 Chinese Journal of Biologicals
关键词 EB病毒 小肠上皮细胞 MAPK通路 磷酸化 EB virus (EBV) Intestinal epithelial cells MAPK pathway Phosphorylation
  • 相关文献

参考文献5

二级参考文献17

  • 1王晓莉,于洁.EB病毒感染及其相关性疾病[J].国外医学(儿科学分册),2005,32(5):287-290. 被引量:20
  • 2星学花.儿童EB病毒(EBV)感染50例临床分析[J].青海医药杂志,2006,36(4):21-22. 被引量:1
  • 3邓路瑶,肖雨萌,黄鹤,贺琼,徐兰,郭晓丹,王学瑛,王月丹.Epstein-Barr病毒舆其相网疾病研究造展[J].Journal of US-China Medical Science,2007,4(6):41-44. 被引量:3
  • 4Henter Jl, Horne A, Aric6 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124- 131.
  • 5Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment[J]. Hematology Am Soc Hematol Educ Program, 2013, 2013:605-611.
  • 6Kucik C J, Martin GL, Sortor BV. Common intestinal parasites[J]. Am Fam Physician, 2004, 69(5): 1161-1168.
  • 7Stark D, Barratt JL, van Hal S, et al. Clinical significance of enteric protozoa in the immunosuppressed human population[J]. Clin Microbiol Rev, 2009, 22(4): 634-650.
  • 8Li E, Zhao A, Shea-Donohue T, et al, Mast cell-mediated changes in smooth muscle contractility during mouse giardiasis[J]. Infect Immun, 2007, 75(9): 4514-4518.
  • 9Belosevic M, Daniels CW. Phagocytosis of Giardia lamblia trophozoites by cytokine-activated macrophages[J]. Clin Exp Immunol, 1992, 87(2): 304-309.
  • 10Singer SM, Nash TE. T-cell-dependent control of acute Giardia lamblia infections in mice[J]. Infect lmmun, 2000, 68(1): 170- 175.

共引文献13

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部